Alterations in whole-body arginine metabolism in chronic obstructive pulmonary disease.

Jonker, R.,Deutz, N. E.,Erbland, M. L.,Anderson, P. J.,Engelen, M. P.; Am. J. Clin. Nutr.. 1900 Jan 01.

Hydrolyzed casein and whey protein meals comparably stimulate net whole-body protein synthesis in COPD patients with nutritional depletion without an additional effect of leucine co-ingestion

Jonker, R.,Deutz, N. E.,Erbland, M. L.,Anderson, P. J.,Engelen, M. P.; Clin Nutr. 2013 Jul 1.

Chronic obstructive pulmonary disease: an update on diagnosis and management issues in older adults

Nazir, S. A., Erbland, M. L.; Drugs Aging. 2009 Sep 19.

Interaction of hypoxia and hypercapnia on respiratory drive in patients with COPD

Erbland, M. L., Ebert, R. V., Snow, S. L.; Chest. 1990 Jun.

Systemic Corticosteroids in Chronic Obstructive Pulmonary Disease Exacerbations (SCCOPE): rationale and design of an equivalence trial. Veterans Administration Cooperative Trials SCCOPE Study Group.

Erbland, M. L., Deupree, R. H., Niewoehner, D. E.; Control Clin Trials. 1998 Aug.

Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group.

Niewoehner, D. E., Erbland, M. L., Deupree, R. H., Collins, D., Gross, N. J., Light, R. W., Anderson, P., Morgan, N. A.; N Engl J Med. 1999 Jun 24.

Relation of FEV(1) to clinical outcomes during exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group.

Niewoehner, D. E., Collins, D., Erbland, M. L.; Am J Respir Crit Care Med. 2000 Apr.